These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28469363)

  • 1. Importance of miR-299-5p in colorectal cancer.
    Fateh A; Feizi MAH; Safaralizadeh R; Azarbarzin S
    Ann Gastroenterol; 2017; 30(3):322-326. PubMed ID: 28469363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of miR-205 in colorectal cancer.
    Orang AV; Safaralizadeh R; Hosseinpour Feizi MA; Somi MH
    Asian Pac J Cancer Prev; 2014; 15(9):4033-7. PubMed ID: 24935592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Value of miR-1287 in Colorectal Cancer.
    Fateh A; Feizi MA; Safaralizadeh R; Azarbarzin S; Ravanbakhsh R
    J Gastrointest Cancer; 2016 Dec; 47(4):399-403. PubMed ID: 27251300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
    Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
    Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z
    Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF.
    Wang Z; Ma B; Ji X; Deng Y; Zhang T; Zhang X; Gao H; Sun H; Wu H; Chen X; Zhao R
    Cancer Cell Int; 2015; 15():40. PubMed ID: 25977643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
    Li Q; Liang X; Wang Y; Meng X; Xu Y; Cai S; Wang Z; Liu J; Cai G
    Sci Rep; 2016 May; 6():27157. PubMed ID: 27244080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of specific microRNAs in tissue and plasma in colorectal cancer.
    Fellizar A; Refuerzo V; Ramos JD; Albano PM
    J Pathol Transl Med; 2023 May; 57(3):147-157. PubMed ID: 35501673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1224-5p Inhibits Metastasis and Epithelial-Mesenchymal Transition in Colorectal Cancer by Targeting SP1-Mediated NF-κB Signaling Pathways.
    Li J; Peng W; Yang P; Chen R; Gu Q; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
    Front Oncol; 2020; 10():294. PubMed ID: 32231999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1.
    Ke SB; Qiu H; Chen JM; Shi W; Chen YS
    Gene; 2018 Nov; 676():329-335. PubMed ID: 30144500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.